Skip to main content

Search UC San Diego Today

Keyword is required

Your search for “COVID-19” returned 547 results

Loss of Smell and Taste Validated as COVID-19 Symptoms

Researchers at UC San Diego Health publish the first empirical findings that strongly associate sensory loss and COVID-19, the respiratory disease caused by the novel coronavirus.

Kids With MIS-C Mount Normal T Cell Response to COVID-19

UC San Diego study suggests multisystem inflammatory syndrome in children (MIS-C), a rare condition associated with COVID-19, is not caused by abnormal T cell response to COVID-19 virus as previously hypothesized.

UC San Diego Health Offers Virtual Appointments to Patients with COVID-19

UC San Diego Health now offers a telemedicine clinic to help patients with COVID-19 recover at home.

Study: COVID-19 Infection Combined with Blood Clots Worsen Patient Outcomes

While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with an increased tendency of the blood to clot, leading to a higher risk of death from COVID-19.

Young, Healthy Woman Suffers Brain Inflammation after Mild COVID-19 Infection

UC San Diego Health physicians describe first known case of young, healthy adult experiencing central nervous system inflammation due to COVID-19, but without cognitive impairment.

Disparities in United States COVID-19 Vaccine Distribution

Health care facilities in Black metropolitan counties, Hispanic rural counties and hardest-hit counties were less likely to administer COVID-19 vaccines during initial rollout, UC San Diego study finds.

Treated or Not, COVID-19 Recurrence Seems Symptomatic for Some

UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive days, but then subsequently reported a return of symptoms.

Arthritis Drug Presents Promise as Treatment for COVID-19 Pneumonia

UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.

Using Ultrasound Stimulation to Reduce Inflammation in COVID-19 In-Patients

Researchers at UC San Diego School of Medicine have begun a pilot clinical trial to test the efficacy of using ultrasound to stimulate the spleen and reduce COVID-19-related inflammation, decreasing the length of hospital stays.

UC San Diego Health Launches Clinical Trial to Assess Antiviral Drug for COVID-19

Researchers at four University of California Health medical centers have begun recruiting participants for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients with COVID-19 with remdesivir, a drug that has shown promising activity against multiple viruses.